Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Healthtrust
AstraZeneca
Cipla
Chinese Patent Office
Federal Trade Commission
Mallinckrodt
Baxter
Dow
Boehringer Ingelheim

Generated: February 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,464,632

« Back to Dashboard

Summary for Patent: 5,464,632
Title: Rapidly disintegratable multiparticular tablet
Abstract:Rapidly disintegratable multiparticulate tablet the excipient mixture of which is suitable for imparting a disintegration rate such that the tablet disintegrates in the mouth in an extremely short time, notably in less than sixty seconds, characterized by the fact that the active substance is present in the form of coated microcrystals or coated or uncoated microgranules.
Inventor(s): Cousin; Gerard (Gallardon, FR), Bruna; Etienne (Chartres, FR), Gendrot; Edouard (Vernouillet, FR)
Assignee: Laboratoires Prographarm (Chateauneuf, FR)
Application Number:08/346,324
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound; Dosage form; Use;

Drugs Protected by US Patent 5,464,632

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,464,632

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France91 09245Jul 22, 1991

International Patents Family Members for US Patent 5,464,632

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 148339 ➤ Sign Up
Australia 2417192 ➤ Sign Up
Australia 666666 ➤ Sign Up
Canada 2092074 ➤ Sign Up
Germany 69217191 ➤ Sign Up
Denmark 0548356 ➤ Sign Up
European Patent Office 0548356 ➤ Sign Up
Spain 2099275 ➤ Sign Up
France 2679451 ➤ Sign Up
Greece 3023281 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
UBS
Cipla
Harvard Business School
Accenture
Fish and Richardson
Baxter
Queensland Health
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot